Plasma enhance drug sensitivity to bortezomib by inhibition of cyp1a1 in myeloma cells.
Journal Information
Full Title: Transl Cancer Res
Abbreviation: Transl Cancer Res
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/tcr.2019.10.43). The authors have no conflicts of interest to declare."
"Funding: This work is supported by the National Natural Science Foundation of China ( Grant No. 51521065 ), First Class of China Postdoctoral Science Foundation ( 2017M610639 ) and Special Fund of China Postdoctoral Science Foundation, the Fundamental Research Funds for Central Universities, State Key Laboratory of Electrical Insulation and Power Equipment ( EIPE18312 ) and Special Fund of Shaanxi Postdoctoral Science Foundation ( 2017BSHTDZZ04 )."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025